When.com Web Search

  1. Ads

    related to: pde5 inhibitors for bph symptoms in dogs treatment

Search results

  1. Results From The WOW.Com Content Network
  2. Silodosin - Wikipedia

    en.wikipedia.org/wiki/Silodosin

    Silodosin, sold under the brand name Urief among others, is a medication used for the symptomatic treatment of benign prostatic hyperplasia. [4] [5] It acts as an alpha-1 adrenergic receptor antagonist. [4] [5] The most common side effect is a reduction in the amount of semen released during ejaculation. [5]

  3. PDE5 inhibitor - Wikipedia

    en.wikipedia.org/wiki/PDE5_inhibitor

    Sildenafil and tadalafil are also indicated for the treatment of some subtypes of pulmonary hypertension, while tadalafil is also licensed for the treatment of benign prostatic hyperplasia. [1] PDE5 inhibitors have been used as a second line therapy in severe cases of Raynaud phenomenon when it is related to systemic sclerosis per The European ...

  4. Phosphodiesterase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Phosphodiesterase_inhibitor

    A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers, cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s). The ubiquitous presence of this ...

  5. List of phosphodiesterase inhibitors - Wikipedia

    en.wikipedia.org/wiki/List_of_phosphodiesterase...

    Adibendan; Aminophylline; Aminophylline dihydrate; Amipizone; Apremilast; Arofylline; Atizoram; Befuraline; Bemarinone hydrochloride; Bemoradan; Benafentrine; Bucladesine

  6. Cialis and Alcohol: Is it Safe?

    www.aol.com/cialis-alcohol-safe-115800912.html

    PDE5 inhibitors like Cialis are the first line of treatment for ED. They can help you get an arousal by relaxing the blood vessels in your privates and boosting blood flow to the area .

  7. cGMP-specific phosphodiesterase type 5 - Wikipedia

    en.wikipedia.org/wiki/CGMP-specific_phosphodi...

    Sildenafil (marketed as Viagra) was the first PDE5 inhibitor on the market. Originally created as a treatment for high blood pressure in 1989, it was found to have a secondary use as an effective PDE5 inhibitor, enabling men who use it to gain stronger erections after arousal. The FDA approved Viagra on March 27, 1998. [20]